MK-4646
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MK-4646, covering 2026-01-29 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646) [Phase 1]